mirtazapine has been researched along with Colonic Diseases, Functional in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Colonic Diseases, Functional: Chronic or recurrent colonic disorders without an identifiable structural or biochemical explanation. The widely recognized IRRITABLE BOWEL SYNDROME falls into this category.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alda Díez, M | 1 |
| Espuelas Monge, M | 1 |
| García-Campayo, J | 1 |
| Thomas, SG | 1 |
2 other studies available for mirtazapine and Colonic Diseases, Functional
| Article | Year |
|---|---|
[Dolichocolon as unwanted effect of treatment with the anti-depressant mirtazapine].
Topics: Adult; Antidepressive Agents, Tricyclic; Colon; Colonic Diseases, Functional; Female; Humans; Mianse | 2004 |
Irritable bowel syndrome and mirtazapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Colonic Diseases, Functional; Drug Administration Schedule; | 2000 |